DK0914818T3 - Intraoralt hurtigt desintegrerbar tablet - Google Patents

Intraoralt hurtigt desintegrerbar tablet

Info

Publication number
DK0914818T3
DK0914818T3 DK97927372T DK97927372T DK0914818T3 DK 0914818 T3 DK0914818 T3 DK 0914818T3 DK 97927372 T DK97927372 T DK 97927372T DK 97927372 T DK97927372 T DK 97927372T DK 0914818 T3 DK0914818 T3 DK 0914818T3
Authority
DK
Denmark
Prior art keywords
disintegrable tablet
tablet
intraoral fast
fast disintegrable
intraoral
Prior art date
Application number
DK97927372T
Other languages
Danish (da)
English (en)
Inventor
Eiji Hayakawa
Motohiro Ohta
Kunio Ito
Sanji Tokuno
Kiyoshi Morimoto
Yasushi Watanabe
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26412238&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0914818(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of DK0914818T3 publication Critical patent/DK0914818T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK97927372T 1996-06-14 1997-06-12 Intraoralt hurtigt desintegrerbar tablet DK0914818T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP15355396 1996-06-14
JP7110797 1997-03-25
PCT/JP1997/002032 WO1997047287A1 (en) 1996-06-14 1997-06-12 Intraorally rapidly disintegrable tablet
EP97927372A EP0914818B1 (en) 1996-06-14 1997-06-12 Intraorally rapidly disintegrable tablet

Publications (1)

Publication Number Publication Date
DK0914818T3 true DK0914818T3 (da) 2005-07-04

Family

ID=26412238

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97927372T DK0914818T3 (da) 1996-06-14 1997-06-12 Intraoralt hurtigt desintegrerbar tablet

Country Status (13)

Country Link
US (1) US20010014340A1 (cg-RX-API-DMAC7.html)
EP (2) EP0914818B1 (cg-RX-API-DMAC7.html)
JP (4) JP3797387B2 (cg-RX-API-DMAC7.html)
CN (1) CN1154479C (cg-RX-API-DMAC7.html)
AT (2) ATE297191T1 (cg-RX-API-DMAC7.html)
AU (1) AU733032C (cg-RX-API-DMAC7.html)
CA (1) CA2258159C (cg-RX-API-DMAC7.html)
DE (2) DE69733476T2 (cg-RX-API-DMAC7.html)
DK (1) DK0914818T3 (cg-RX-API-DMAC7.html)
EA (1) EA001898B1 (cg-RX-API-DMAC7.html)
ES (1) ES2243998T3 (cg-RX-API-DMAC7.html)
PT (1) PT914818E (cg-RX-API-DMAC7.html)
WO (1) WO1997047287A1 (cg-RX-API-DMAC7.html)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733032C (en) * 1996-06-14 2002-01-03 Kyowa Hakko Kirin Co., Ltd. Intraorally rapidly disintegrable tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4568426B2 (ja) * 1998-04-08 2010-10-27 協和発酵キリン株式会社 錠剤の製造方法及び錠剤
EP1070497A4 (en) * 1998-04-10 2009-01-21 Kyowa Hakko Kogyo Kk Tablet manufacturing methods and tablet
PT1121103E (pt) 1998-05-18 2007-02-28 Takeda Pharmaceutical Comprimidos de desintegração oral compreendendo um benzimidazole
ATE308343T1 (de) 1998-07-15 2005-11-15 Asahi Kasei Chemicals Corp Trägerhilfstoff
ATE481090T1 (de) 1998-07-28 2010-10-15 Takeda Pharmaceutical Leicht zerfallende feste zubereitung
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
JP2000178204A (ja) * 1998-10-05 2000-06-27 Eisai Co Ltd ホスフォジエステラ―ゼ阻害剤を含有する口腔内速崩壊性錠剤
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
EP1203580A4 (en) 1999-06-18 2004-06-30 Takeda Chemical Industries Ltd QUICKLY DISINTERABLE SOLID PREPARATIONS
JP4817573B2 (ja) * 1999-10-13 2011-11-16 協和発酵バイオ株式会社 圧縮成形物及びその製造方法
CN100342846C (zh) * 1999-10-13 2007-10-17 协和发酵工业株式会社 压缩成形品及其制备方法
ES2336539T3 (es) * 2000-01-17 2010-04-14 Eurand Pharmaceuticals Ltd Pastilla efervescente, pastilla efervescente para un aditivo de baño, pastilla efervescente para un detergente de lavado, pastilla efervescente para su administracion oral y procedimientos de produccion de las mismas.
US20030104066A1 (en) * 2000-03-27 2003-06-05 Kouji Murai Easy-to-take granules
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
JP4840549B2 (ja) * 2000-11-20 2011-12-21 トーアエイヨー株式会社 安定な血管拡張剤及びその製造方法
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
KR20030081489A (ko) * 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 당알콜을 함유하는 분무건조 분말의 용도
KR20030081472A (ko) * 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 구강내 속붕괴성 제제
WO2002069933A1 (fr) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Comprimés à délitement rapide dans la bouche
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
CN100490798C (zh) * 2001-11-13 2009-05-27 协和发酵麒麟株式会社 含有l-谷氨酰胺和薁磺酸钠的速崩片剂或口腔内崩解片剂及其制造方法
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
US20050147666A1 (en) * 2002-03-06 2005-07-07 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
US20050208127A1 (en) * 2002-06-10 2005-09-22 Kazuyoshi Ogasawara Rapidly disintegrating tablet and process for producing the same
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
FR2845914B1 (fr) * 2002-10-18 2005-11-04 Schwarz Pharma Lab Compose antiemetique a desagregation rapide
DE10248652A1 (de) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Verfahren zur Herstellung von staubfreien Erdalkaliperoxiden
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
JP5584509B2 (ja) * 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
JP4551627B2 (ja) * 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
GB2404662A (en) * 2003-08-01 2005-02-09 Reckitt Benckiser Cleaning composition
US8545881B2 (en) * 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
BRPI0511520B8 (pt) 2004-05-24 2021-05-25 Nycomed Pharma As material particulado, forma de dosagem sólida, e, processos para a preparação de um material particulado, e para preparar um comprimido
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
MY139913A (en) 2004-06-01 2009-11-30 Nycomed Pharma As Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) * 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
CN102631289B (zh) * 2004-10-28 2016-05-04 潘特克股份公司 高孔隙度的速崩固体剂型及其包括生产粉末和冻干步骤的制备方法
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
WO2006082499A1 (en) 2005-02-03 2006-08-10 Nycomed Pharma As Melt granulation of a composition containing a calcium-containing compound
CN101128186B (zh) 2005-02-03 2013-07-03 奈科明制药有限公司 制备含钙组合物的快速湿聚结方法
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9757455B2 (en) * 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
CN101365426B (zh) 2005-12-07 2012-08-08 奈科明制药有限公司 预先压实的含钙组合物
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
WO2007079758A1 (de) * 2005-12-21 2007-07-19 Add Advanced Drug Delivery Technologies Ltd. Pellets enthaltend einen kern mit einem wasserlöslichen träger
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
KR101324898B1 (ko) * 2006-03-31 2013-11-04 루비콘 리서치 피브이티. 엘티디. 구강 붕해 정제
NZ575171A (en) 2006-08-31 2012-04-27 Aptalis Pharmatech Inc Drug delivery systems comprising solid solutions of weakly basic drugs
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
BRPI0808889A2 (pt) * 2007-03-13 2014-11-11 Dainippon Sumitomo Pharma Co Comprimido desintegrante oral
EP1977734A1 (en) * 2007-04-03 2008-10-08 Royal College of Surgeons in Ireland A method of producing fast dissolving tablets
JP4980144B2 (ja) * 2007-06-05 2012-07-18 日機装株式会社 固型化透析用剤の製造方法
US20100292341A1 (en) * 2007-06-29 2010-11-18 Orchid Chemicals & Pharmaceuticals Limited Quick dissolve compositions of memantine hydrochloride
JP5537943B2 (ja) * 2007-09-27 2014-07-02 田辺三菱製薬株式会社 速崩壊性固形製剤
WO2009084678A1 (ja) * 2007-12-28 2009-07-09 Sawai Pharmaceutical Co., Ltd. 口腔内崩壊錠およびその製造方法
PL2356989T3 (pl) 2008-10-24 2018-07-31 Toray Industries, Inc. Trwała tabletka zawierająca pochodną 4,5-epoksymorfinanu
HRP20131084T1 (hr) 2008-11-17 2013-12-20 Takeda Nycomed As Poboljšana stabilnost topljivosti tableta kalcijeva karbonata
US20110229570A1 (en) 2008-11-25 2011-09-22 Masaaki Sugimoto Orally rapidly disintegrating tablet and process for producing same
TR200903014A1 (tr) * 2009-04-17 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan dimebolin bileşimleri.
ES2742525T3 (es) 2009-10-01 2020-02-14 Adare Pharmaceuticals Us L P Composiciones de corticosteroides administradas oralmente
KR20120101437A (ko) 2009-11-09 2012-09-13 가부시키가이샤 니콘 노광 장치, 노광 방법, 노광 장치의 메인터넌스 방법, 노광 장치의 조정 방법, 및 디바이스 제조 방법
SG10201407947WA (en) 2009-11-30 2015-01-29 Aptalis Pharmatech Inc Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
MX2013008314A (es) 2011-01-17 2013-09-26 Takeda Pharmaceutical Tableta dispersable en forma oral.
JP6061516B2 (ja) * 2011-07-14 2017-01-18 協和発酵キリン株式会社 ドンペリドン口腔内崩壊錠
JP6061924B2 (ja) 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
JP6004882B2 (ja) * 2012-10-15 2016-10-12 三菱商事フードテック株式会社 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
JP2022130075A (ja) * 2021-02-25 2022-09-06 フロイント産業株式会社 顆粒及びその製造方法、並びに錠剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
IE45770B1 (en) 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
JPS5614098A (en) * 1979-07-13 1981-02-10 Takeda Chem Ind Ltd Externally lubricating tablet making machine
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
JPH0774153B2 (ja) * 1986-04-14 1995-08-09 三共株式会社 ロキソプロフェン・ナトリウム含有製剤
JPS63162619A (ja) * 1986-12-25 1988-07-06 Teisan Seiyaku Kk 遅溶性顆粒及びそれを用いた持続性複合顆粒
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
HU200926B (en) 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
JP2781442B2 (ja) * 1990-02-19 1998-07-30 旭化成工業株式会社 顆粒含有錠剤
KR100256147B1 (ko) 1991-12-24 2000-08-01 오노다 마사요시 구강내 붕해성 제제 및 이의 제조방법
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
ATE210968T1 (de) 1992-02-18 2002-01-15 Nippon Shinyaku Co Ltd Verfahren zur herstellung von schnelllöslicher tabletten und schnelllöslichen tablette beinhaltend xylitol
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
AU733032C (en) * 1996-06-14 2002-01-03 Kyowa Hakko Kirin Co., Ltd. Intraorally rapidly disintegrable tablet

Also Published As

Publication number Publication date
EA001898B1 (ru) 2001-10-22
EP0914818A4 (en) 2001-03-14
ES2243998T3 (es) 2005-12-01
JP2006077018A (ja) 2006-03-23
EA199900028A1 (ru) 1999-06-24
CA2258159C (en) 2006-03-21
EP0914818B1 (en) 2005-06-08
CA2258159A1 (en) 1997-12-18
JP2012167105A (ja) 2012-09-06
JP5484514B2 (ja) 2014-05-07
AU3189597A (en) 1998-01-07
DE69733476D1 (de) 2005-07-14
JP2009256372A (ja) 2009-11-05
DE69733476T2 (de) 2006-03-23
CN1224349A (zh) 1999-07-28
JP3797387B2 (ja) 2006-07-19
ATE477793T1 (de) 2010-09-15
ATE297191T1 (de) 2005-06-15
CN1154479C (zh) 2004-06-23
US20010014340A1 (en) 2001-08-16
EP1598061A1 (en) 2005-11-23
EP0914818A1 (en) 1999-05-12
AU733032C (en) 2002-01-03
PT914818E (pt) 2005-08-31
EP1598061B1 (en) 2010-08-18
WO1997047287A1 (en) 1997-12-18
DE69739967D1 (de) 2010-09-30
AU733032B2 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
DK0914818T3 (da) Intraoralt hurtigt desintegrerbar tablet
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
GR3035308T3 (en) Bioadhesive pharmaceutical composition for controlled release of drugs.
NO971206D0 (no) Forlenget-frigjöringsformulering
CA2085466A1 (en) Intermittent threaded dental posts
DE69006385D1 (de) Pharmazeutische Formulierung.
CA2186039A1 (en) New oral pharmaceutical dosage form
AU651894B2 (en) Matrix tablet permitting the sustained release of indapamide after oral administration
CA2093282A1 (en) Intraoral medicament-releasing device
DE3678640D1 (de) Geschmack abdeckende zusammensetzungen.
KR960702322A (ko) 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하며 약효가 개선된 정제 (more easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent)
DK0427124T3 (da) Antacidatabletter
RU93020831A (ru) Зубной эликсир
HUP9901021A2 (hu) Famciklovirt nagy koncentrációban tartalmazó gyógyászati tabletták
FR2675015B1 (fr) Compositions destinees a la protection et a l'elimination des parasites humains, en particulier pediculus capitis et corporis, comportant des acetylpolyaminoacides, des extraits de ginkgo biloba et de propolis.
IT8821437A0 (it) Procedimento per prolungare la permanenza nel tratto gastrointestinale di farmaci in formulazioni ad effetto prolungato e forme di dosaggio cosi' ottenute.